Skip to main content

Peer Review reports

From: Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

Original Submission
27 Dec 2020 Submitted Original manuscript
12 Feb 2021 Reviewed Reviewer Report
27 Feb 2021 Reviewed Reviewer Report
3 Mar 2021 Reviewed Reviewer Report
26 Mar 2021 Author responded Author comments - Yang Yang
Resubmission - Version 2
26 Mar 2021 Submitted Manuscript version 2
31 Mar 2021 Reviewed Reviewer Report
1 Apr 2021 Reviewed Reviewer Report
16 Apr 2021 Reviewed Reviewer Report
10 May 2021 Author responded Author comments - Yang Yang
Resubmission - Version 3
10 May 2021 Submitted Manuscript version 3
Publishing
11 May 2021 Editorially accepted
19 May 2021 Article published 10.1186/s12890-021-01539-x

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us